AxoGen, Inc. (0HKD.L)
USD 16.93
(0.5%)
USD 16.93
(0.5%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -21.71 Million USD | 20.56% |
| 2022 | -27.33 Million USD | 2.59% |
| 2021 | -28.06 Million USD | -13.15% |
| 2020 | -24.8 Million USD | 14.83% |
| 2019 | -29.12 Million USD | -30.03% |
| 2018 | -22.39 Million USD | -114.42% |
| 2017 | -10.44 Million USD | 27.52% |
| 2016 | -14.41 Million USD | -7.9% |
| 2015 | -13.35 Million USD | 24.58% |
| 2014 | -17.71 Million USD | -21.66% |
| 2013 | -14.55 Million USD | -54.57% |
| 2012 | -9.41 Million USD | -2.16% |
| 2011 | -9.21 Million USD | -600.39% |
| 2010 | -1.31 Million USD | -108.75% |
| 2009 | 15.04 Million USD | 1545.78% |
| 2008 | -1.04 Million USD | -38.95% |
| 2007 | -748.98 Thousand USD | -103.98% |
| 2006 | -367.18 Thousand USD | 30.8% |
| 2005 | -530.61 Thousand USD | -123.1% |
| 2004 | 2.29 Million USD | 279.18% |
| 2003 | -1.28 Million USD | 50.75% |
| 2002 | -2.6 Million USD | -293.73% |
| 2001 | 1.34 Million USD | 146.99% |
| 2000 | -2.85 Million USD | -68.19% |
| 1999 | -1.7 Million USD | -325.0% |
| 1998 | -400 Thousand USD | 82.61% |
| 1997 | -2.3 Million USD | -283.33% |
| 1996 | -600 Thousand USD | -400.0% |
| 1995 | 200 Thousand USD | -66.67% |
| 1994 | 600 Thousand USD | -14.29% |
| 1993 | 700 Thousand USD | -30.0% |
| 1992 | 1 Million USD | 11.11% |
| 1991 | 900 Thousand USD | 125.0% |
| 1990 | 400 Thousand USD | -33.33% |
| 1989 | 600 Thousand USD | -33.33% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -6.63 Million USD | -70.43% |
| 2024 Q2 | -1.92 Million USD | 71.05% |
| 2023 Q4 | -3.89 Million USD | 4.79% |
| 2023 Q2 | -6.66 Million USD | 0.75% |
| 2023 Q3 | -4.08 Million USD | 38.6% |
| 2023 Q1 | -6.71 Million USD | -30.82% |
| 2023 FY | -21.71 Million USD | 20.56% |
| 2022 Q2 | -7.74 Million USD | 31.32% |
| 2022 Q3 | -3.66 Million USD | 52.67% |
| 2022 Q4 | -5.12 Million USD | -40.02% |
| 2022 Q1 | -11.26 Million USD | -113.19% |
| 2022 FY | -27.33 Million USD | 2.59% |
| 2021 Q3 | -7.14 Million USD | 9.58% |
| 2021 Q1 | -6.66 Million USD | -10.82% |
| 2021 FY | -28.06 Million USD | -13.15% |
| 2021 Q4 | -5.28 Million USD | 25.98% |
| 2021 Q2 | -7.89 Million USD | -18.59% |
| 2020 Q1 | -8.19 Million USD | -16.4% |
| 2020 FY | -24.8 Million USD | 14.83% |
| 2020 Q4 | -6.01 Million USD | -306.36% |
| 2020 Q3 | -1.47 Million USD | 81.75% |
| 2020 Q2 | -8.1 Million USD | 1.06% |
| 2019 Q1 | -9.5 Million USD | -81.93% |
| 2019 FY | -29.12 Million USD | -30.03% |
| 2019 Q3 | -5.57 Million USD | 20.67% |
| 2019 Q4 | -7.03 Million USD | -26.33% |
| 2019 Q2 | -7.02 Million USD | 26.1% |
| 2018 Q3 | -4.1 Million USD | 44.78% |
| 2018 Q4 | -5.22 Million USD | -27.36% |
| 2018 FY | -22.39 Million USD | -114.42% |
| 2018 Q2 | -7.42 Million USD | -31.73% |
| 2018 Q1 | -5.63 Million USD | -125.62% |
| 2017 Q1 | -3.76 Million USD | 33.14% |
| 2017 Q2 | -2.06 Million USD | 45.24% |
| 2017 Q3 | -2.12 Million USD | -3.1% |
| 2017 FY | -10.44 Million USD | 27.52% |
| 2017 Q4 | -2.49 Million USD | -17.66% |
| 2016 Q2 | -2.8 Million USD | 23.76% |
| 2016 Q1 | -3.67 Million USD | -1.79% |
| 2016 FY | -14.41 Million USD | -7.9% |
| 2016 Q3 | -2.3 Million USD | 17.74% |
| 2016 Q4 | -5.62 Million USD | -144.08% |
| 2015 FY | -13.35 Million USD | 24.58% |
| 2015 Q4 | -3.61 Million USD | -21.24% |
| 2015 Q1 | -3.57 Million USD | 44.92% |
| 2015 Q2 | -3.19 Million USD | 10.75% |
| 2015 Q3 | -2.97 Million USD | 6.64% |
| 2014 Q1 | -4.23 Million USD | -3.18% |
| 2014 FY | -17.71 Million USD | -21.66% |
| 2014 Q4 | -6.49 Million USD | -100.46% |
| 2014 Q3 | -3.23 Million USD | 13.45% |
| 2014 Q2 | -3.74 Million USD | 11.75% |
| 2013 Q4 | -4.1 Million USD | -15.65% |
| 2013 Q2 | -3.45 Million USD | -0.59% |
| 2013 Q1 | -3.43 Million USD | 14.96% |
| 2013 FY | -14.55 Million USD | -54.57% |
| 2013 Q3 | -3.55 Million USD | -2.75% |
| 2012 Q4 | -4.04 Million USD | -80.71% |
| 2012 FY | -9.41 Million USD | -2.16% |
| 2012 Q3 | -2.23 Million USD | -117.23% |
| 2012 Q2 | -1.02 Million USD | 51.18% |
| 2012 Q1 | -2.1 Million USD | 1.29% |
| 2011 Q1 | 905.21 Thousand USD | 341.34% |
| 2011 Q2 | 250.43 Thousand USD | -72.33% |
| 2011 Q3 | -3.11 Million USD | -1343.09% |
| 2011 FY | -9.21 Million USD | -600.39% |
| 2011 Q4 | -2.13 Million USD | 31.36% |
| 2010 Q3 | -464.91 Thousand USD | -101.79% |
| 2010 Q4 | -375.07 Thousand USD | 19.32% |
| 2010 FY | -1.31 Million USD | -108.75% |
| 2010 Q1 | -245.92 Thousand USD | -101.62% |
| 2010 Q2 | -230.38 Thousand USD | 6.32% |
| 2009 Q4 | 15.17 Million USD | 11684.57% |
| 2009 FY | 15.04 Million USD | 1545.78% |
| 2009 Q3 | -130.97 Thousand USD | -194.23% |
| 2009 Q1 | -134.46 Thousand USD | -11.32% |
| 2009 Q2 | 138.99 Thousand USD | 203.37% |
| 2008 FY | -1.04 Million USD | -38.95% |
| 2008 Q1 | -159.7 Thousand USD | -716.14% |
| 2008 Q4 | -120.79 Thousand USD | 79.28% |
| 2008 Q3 | -582.83 Thousand USD | -228.59% |
| 2008 Q2 | -177.37 Thousand USD | -11.07% |
| 2007 FY | -748.98 Thousand USD | -103.98% |
| 2007 Q4 | -19.56 Thousand USD | 95.72% |
| 2007 Q3 | -456.99 Thousand USD | -189.07% |
| 2007 Q2 | -158.09 Thousand USD | -38.28% |
| 2007 Q1 | -114.32 Thousand USD | 22.55% |
| 2006 Q3 | -61.92 Thousand USD | 41.61% |
| 2006 Q2 | -106.06 Thousand USD | -105.65% |
| 2006 Q1 | -51.57 Thousand USD | -136.95% |
| 2006 FY | -367.18 Thousand USD | 30.8% |
| 2006 Q4 | -147.62 Thousand USD | -138.39% |
| 2005 FY | -530.61 Thousand USD | -123.1% |
| 2005 Q3 | 379.00 USD | 100.46% |
| 2005 Q2 | -82.31 Thousand USD | 86.01% |
| 2005 Q1 | -588.24 Thousand USD | -156.47% |
| 2005 Q4 | 139.57 Thousand USD | 36727.18% |
| 2004 Q4 | 1.04 Million USD | -11.07% |
| 2004 Q1 | 74.72 Thousand USD | 151.56% |
| 2004 Q2 | 8839.00 USD | -88.17% |
| 2004 FY | 2.29 Million USD | 279.18% |
| 2004 Q3 | 1.17 Million USD | 13152.87% |
| 2003 Q1 | -359.48 Thousand USD | 45.34% |
| 2003 Q2 | -433.54 Thousand USD | -20.6% |
| 2003 Q4 | -144.93 Thousand USD | 57.84% |
| 2003 FY | -1.28 Million USD | 50.75% |
| 2003 Q3 | -343.79 Thousand USD | 20.7% |
| 2002 Q1 | -806.98 Thousand USD | 0.0% |
| 2002 Q4 | -657.73 Thousand USD | -77.55% |
| 2002 Q3 | -370.46 Thousand USD | 51.76% |
| 2002 Q2 | -768 Thousand USD | 4.83% |
| 2002 FY | -2.6 Million USD | -293.73% |
| 2001 FY | 1.34 Million USD | 146.99% |
| 2001 Q3 | -1.19 Million USD | -137.45% |
| 2001 Q2 | 3.17 Million USD | 684.27% |
| 2001 Q1 | -543.78 Thousand USD | 21.42% |
| 2000 Q2 | -817.49 Thousand USD | -27.07% |
| 2000 FY | -2.85 Million USD | -68.19% |
| 2000 Q1 | -643.32 Thousand USD | 19.58% |
| 2000 Q3 | -597.9 Thousand USD | 26.86% |
| 2000 Q4 | -691.99 Thousand USD | -15.74% |
| 1999 Q1 | -300 Thousand USD | 57.14% |
| 1999 FY | -1.7 Million USD | -325.0% |
| 1999 Q4 | -800 Thousand USD | -33.33% |
| 1999 Q3 | -600 Thousand USD | -20.0% |
| 1999 Q2 | -500 Thousand USD | -66.67% |
| 1998 Q1 | -300 Thousand USD | 0.0% |
| 1998 Q3 | -200 Thousand USD | 33.33% |
| 1998 Q4 | -700 Thousand USD | -250.0% |
| 1998 FY | -400 Thousand USD | 82.61% |
| 1998 Q2 | -300 Thousand USD | 0.0% |
| 1997 Q2 | -600 Thousand USD | 60.0% |
| 1997 Q4 | - USD | -100.0% |
| 1997 FY | -2.3 Million USD | -283.33% |
| 1997 Q1 | -1.5 Million USD | -400.0% |
| 1997 Q3 | 200 Thousand USD | 133.33% |
| 1996 Q4 | -300 Thousand USD | 0.0% |
| 1996 Q2 | - USD | -100.0% |
| 1996 FY | -600 Thousand USD | -400.0% |
| 1996 Q1 | 100 Thousand USD | 114.29% |
| 1996 Q3 | - USD | 0.0% |
| 1995 Q2 | -100 Thousand USD | -150.0% |
| 1995 Q4 | -700 Thousand USD | -600.0% |
| 1995 FY | 200 Thousand USD | -66.67% |
| 1995 Q3 | -100 Thousand USD | 0.0% |
| 1995 Q1 | 200 Thousand USD | 0.0% |
| 1994 Q4 | - USD | -100.0% |
| 1994 FY | 600 Thousand USD | -14.29% |
| 1994 Q1 | - USD | -100.0% |
| 1994 Q2 | - USD | 0.0% |
| 1994 Q3 | 100 Thousand USD | 0.0% |
| 1993 Q2 | 200 Thousand USD | 0.0% |
| 1993 Q1 | 200 Thousand USD | 100.0% |
| 1993 FY | 700 Thousand USD | -30.0% |
| 1993 Q4 | 200 Thousand USD | -50.0% |
| 1993 Q3 | 400 Thousand USD | 100.0% |
| 1992 Q1 | 200 Thousand USD | -33.33% |
| 1992 Q2 | 200 Thousand USD | 0.0% |
| 1992 Q3 | 200 Thousand USD | 0.0% |
| 1992 Q4 | 100 Thousand USD | -50.0% |
| 1992 FY | 1 Million USD | 11.11% |
| 1991 Q1 | 200 Thousand USD | 0.0% |
| 1991 Q4 | 300 Thousand USD | 0.0% |
| 1991 Q3 | 300 Thousand USD | 50.0% |
| 1991 FY | 900 Thousand USD | 125.0% |
| 1991 Q2 | 200 Thousand USD | 0.0% |
| 1990 FY | 400 Thousand USD | -33.33% |
| 1990 Q3 | 200 Thousand USD | 109.52% |
| 1990 Q4 | 200 Thousand USD | 0.0% |
| 1990 Q1 | -200 Thousand USD | 0.0% |
| 1990 Q2 | -2.1 Million USD | -950.0% |
| 1989 Q1 | - USD | 0.0% |
| 1989 Q4 | - USD | -100.0% |
| 1989 FY | 600 Thousand USD | -33.33% |
| 1989 Q3 | 200 Thousand USD | 0.0% |
| 1989 Q2 | - USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Phreesia, Inc. | -136.88 Million USD | 84.136% |
| Accuray Incorporated | -15.54 Million USD | -39.698% |
| Align Technology, Inc. | 445.05 Million USD | 104.879% |
| Elevance Health Inc. | 5.98 Billion USD | 100.363% |
| Boston Scientific Corporation | 1.59 Billion USD | 101.363% |
| CVS Health Corporation | 8.34 Billion USD | 100.26% |
| Cardinal Health, Inc. | 852 Million USD | 102.549% |
| Centene Corporation | 2.7 Billion USD | 100.804% |
| DaVita Inc. | 691.53 Million USD | 103.14% |
| HCA Healthcare, Inc. | 5.24 Billion USD | 100.414% |
| Hologic, Inc. | 789.5 Million USD | 102.751% |
| Humana Inc. | 2.48 Billion USD | 100.872% |
| IDEXX Laboratories, Inc. | 845.04 Million USD | 102.57% |
| Laboratory Corporation of America Holdings | 418 Million USD | 105.195% |
| Masimo Corporation | 81.5 Million USD | 126.645% |
| McKesson Corporation | 3 Billion USD | 100.723% |
| Patterson Companies, Inc. | 185.93 Million USD | 111.68% |
| Quest Diagnostics Incorporated | 854 Million USD | 102.543% |
| ResMed Inc. | 1.02 Billion USD | 102.127% |
| Henry Schein, Inc. | 416 Million USD | 105.22% |
| Teladoc Health, Inc. | -220.36 Million USD | 90.146% |
| Universal Health Services, Inc. | 717.79 Million USD | 103.025% |
| Veeva Systems Inc. | 525.7 Million USD | 104.131% |
| Baxter International Inc. | 2.65 Billion USD | 100.818% |
| Becton, Dickinson and Company | 1.48 Billion USD | 101.463% |
| Intuitive Surgical, Inc. | 1.79 Billion USD | 101.208% |
| Danaher Corporation | 4.2 Billion USD | 100.517% |
| Stryker Corporation | 3.16 Billion USD | 100.686% |
| Medtronic plc | 3.67 Billion USD | 100.591% |